Obesity

Obesity is a Biochemical Phenomenon

Obesity is a Biochemical Phenomenon

The greatest challenge to health provision in virtually every country across the globe is obesity; the scale of the epidemic threatens to outstrip resources in even the richest of societies. The burden of morbidity arising from obesity and its sequelae of type 2 diabetes, cardiovascular disease and cancer present many challenges that are not restricted to those providing healthcare but reaching across society.

Modern Medicine – Issue 2 2020

Obesity Start the discussion

Obesity Start the discussion

Obesity is a serious, chronic, relapsing disease with a high prevalence and a substantial unmet medical need. For every 5-unit increase in BMI above 25kg/m2, overall mortality increases by 29%, vascular mortality by 41% and diabetes-related mortality by 210%.

Modern Medicine – Issue 5 2019

Adjunctive Therapies for Obesity VLEDs, Pharmacotherapy and Bariatric Surgery

Adjunctive Therapies for Obesity VLEDs, Pharmacotherapy and Bariatric Surgery – MM1506

Although lifestyle interventions remain the cornerstone of obesity treatment, this article highlights additional approaches to management that may help reduce and maintain weight. These adjunctive therapies include the role of the multidisciplinary team in obesity management, and the use of very low energy diets, pharmacotherapy and bariatric surgery.

Modern Medicine – June 2015

Grappling with Hypertriglyceridaemia Rosetta Stone or Pandora’s Box?

Grappling with Hypertriglyceridaemia Rosetta Stone or Pandora’s Box? – MM1506

Hypertriglyceridaemia is caused by interactions between many genetic and nongenetic factors and is a common risk factor for atherosclerotic cardiovascular disease (CVD). Treatment of hypertriglyceridaemia relies on correcting secondary factors and unhealthy lifestyle habits, particularly poor diet and lack of exercise. Pharmacotherapy is indicated for patients with established CVD and those at moderate-to-high risk of CVD.

Modern Medicine – June 2015

Glycaemic Control and Weight Loss in Type 2 Diabetes

Glycaemic Control and Weight Loss in Type 2 Diabetes – MM1308

Globally it was estimated in 2010 that there were 285m people living with type 2 diabetes, making up approximately 90% of diabetic cases. Traditionally considered a disease of adults, type 2 diabetes is increasingly diagnosed in children due to rising obesity rates. Type 2 diabetes is diagnosed as  frequently as type 1 diabetes in teenagers in the US. It is recognised as a global epidemic by the World Health Organization.

Modern Medicine – August 2013

Verified by ExactMetrics